This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Menu
Follow UroToday
Centers of Excellence
Urologic Oncology
Left Group
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Rana R. McKay, MD
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mCRPC Treatment
Charles Ryan, MD
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Neal Shore, MD, FACS
A Patient Journey
Alicia Morgans, MD, MPH
Charles J. Ryan, MD
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Transformative Evidence
mCRPC
CARD Trial
PROfound Study
mHSPC
ENZAMET Trial
nmCRPC
PROSPER Trial
Advanced Prostate Cancer
HERO Trial
Bladder Cancer
Bladder Cancer Detection
Videos
Conference Coverage and Experts Group
Interviews with Experts at Conferences
ASCO GU 2021 Bladder and Kidney Cancer
ASCO GU 2021 Prostate Cancer
ASCO 2019
ASCO 2020
ASCO GU 2020
ESMO 2020
Exclusive Collaborations
APCCC 2019
LUGPA Annual Meeting 2019
PCF 2019
SNMMI Curriculum
UroToday Exclusives
Provocative Questions in Prostate Cancer
A Step Towards Personalized Medicine: PSMA PET Imaging in Prostate Cancer
Book Club
Clinical Trials in Progress
Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer
COVID-19 and Genitourinary Cancers Videos
Journal Club
Large Urology Group Practice Association (LUGPA)
Precision Medicine: PSMA Targeted Therapies in Progressive Metastatic Prostate Cancer Videos
Urologic Oncology
Prostate Cancer
Advances in Nuclear Medicine, PET, and Theranostics
Advanced Prostate Cancer
Cardiovascular Disease in Men with Prostate Cancer
CRPC with Bone Metastases
The Expert Voice
Imaging: Prostate Cancer
Localized Prostate Cancer
mCRPC
mHSPC
Molecular Diagnostics
Navigating Cancer
nmCRPC
The Patient Voice
Precision Medicine in Prostate Cancer
Prostate Cancer
Right Group
Bladder Cancer
Bladder Cancer
Bladder Cancer Expert Debates
Advanced Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Kidney Cancer
Advanced Kidney Cancer
Renal Cancer
Upper Tract Urothelial Tumors
Upper Tract Urothelial Carcinoma
Pelvic Health & Reconstruction
Bladder Health
Indwelling Catheters
Intermittent Catheters
Nocturia & Lower Urinary Tract Conditions
Endourology
Endourology Today
Endourology
Testicular Cancer
Testicular Cancer
Journals
Everyday Urology - Oncology Insights
From the Editor
Current Issue
Previous Issues
Prostate Cancer and Prostatic Diseases
From the Editor
Current Article
Previous Articles
Clinical Trials
Clinical Trials
Search Clinical Trials
From the Editor
Current Letter
Previous Letters
Conference Coverage
Advanced Prostate Cancer Consensus Conference (APCCC)
2019 APCCC Meeting
American Society of Clinical Oncology (ASCO)
2021 ASCO GU Symposium
2020 Virtual Education Program
2020 Annual Meeting
2020 ASCO GU Symposium
American Urological Association (AUA)
2020 Annual Meeting
ANZUP Mini Annual Scientific Meeting (ASM)
2020 Virtual Annual Meeting
Bladder Cancer Advocacy Network (BCAN)
2020 Think Tank Virtual Program
EAU Section of Oncological Urology
ESOU 2021
EMUC
2020 Annual Meeting
European Association of Urology (EAU)
2020 Annual Congress
European Society for Medical Oncology (ESMO)
2020 Virtual Congress
Global Society of Rare GU Tumors
2020 Meeting
International Bladder Cancer Network (IBCN)
2020 Annual Virtual Meeting
NMIBC - Drug Development 2021
2021 Annual Meeting
Prostate Cancer Academy
2020 Annual Meeting
Société Internationale d'Urologie (SIU)
2020 Annual Congress
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
2021 Congress
2020 Congress
Society of Urologic Oncology (SUO)
2020 Annual Meeting
2020 SUO - AUA Summer Webcast
Targeted Alpha Therapy (TAT)
2019 Symposium
Articles
Urologic Oncology
Adrenal Diseases
Bladder Cancer
CRPC w/ Bone Metastases
Penile Cancer
Prostate Cancer
Renal Cancer
Upper Tract Tumors
Investigative Urology
Testicular Cancer
Men's Health
Androgen Deficiency
BPH
Erectile Dysfunction
Male Infertility
Peyronie’s Disease
Prostatitis
Vasectomy
Pelvic Health & Reconstruction
Fecal Incontinence
Fistula
GU Trauma & Reconstruction
Indwelling Catheters
Infections
Intermittent Catheters
Interstitial Cystitis
Neurogenic Bladder
Nocturia
Overactive Bladder
Pelvic Prolapse
Post-prostatectomy Incontinence
Stress Incontinence
Underactive Bladder
Urethral Strictures
Urinary Incontinence
Urinary Retention
Urinary Tract Infection – CAUTIs
Urologic Catheters
Endourology & Urolithiasis
Minimally Invasive Procedures
Stone Disease
Pediatric Urology
Pediatric Urology
COVID-19 and Genitourinary Cancers
COVID-19 and Genitourinary Cancers
Calendar
UroToday Home
Transformative Evidence
HERO Study
HERO Study TE: Discussion Videos
Search
Clear
Most recent
Most hits
Most likes
Most dislikes
Title alphabetical
Recently modified
Recently viewed
Author alphabetical
Random
10
20
30
40
50
Patient Selection for ADT Treatment with the Oral GnRH Antagonist in Clinical Practice - Ashley Ross
Details
In this conversation Alicia Morgans, MD, MPH, and Ashley Ross, MD discusses his considerations of patient selection when using the oral GnRH antagonist, relugolix. Dr. Ross explains his thought process when considering oral ADT therapy for his patients, and outlines three specific scenarios when he leans into recommending its use for his patients and his approach to patient follow-up once oral tre...
Impact of Concomitant Prostate Cancer Therapy of Relugolix in Men with Advanced Prostate Cancer - Daniel J. George
Details
Daniel George, MD, and Neal Shore, MD, FACS, co-investigators of the Phase III HERO Trial join Alicia Morgans, MD, MPH recapping the 2021 GU ASCO analysis that Dr. Daniel George presented on the efficacy and safety of relugolix vs leuprolide in men with advanced prostate cancer. This was a subgroup analysis assessing the impact of concomitant prostate cancer therapy on the safety and efficacy of t...
First and Only Oral GnRH Receptor Antagonist Orgovyx for the Treatment of Advanced Prostate Cancer - Charles Ryan & Alicia Morgans
Details
The United States Food and Drug Administration (FDA) approved Orgovyx (relugolix), the first and only oral GnRH receptor antagonist for the treatment of patients with advanced prostate cancer. Alicia Morgans, MD, MPH, and Charles Ryan, MD discuss Orgovyx and what it means to men being treated for advanced prostate cancer who now have an oral ADT treatment option. The FDA approval of Orgovyx is bas...
Journal Club: Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer - Zachary Klaassen
Details
Christopher Wallis and Zachary Klaassen host this journal club on "Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer," published by the HERO trial investigators in the New England Journal of Medicine simultaneously with the first presentation of the trial results at the ASCO 2020 annual meeting. Sharing background information on androgen deprivation therapy (ADT), as well...
HERO Phase III Trial: Results Comparing Relugolix, an Oral GnRH Receptor Antagonist Vs. Leuprolide Acetate for Advanced Prostate Cancer - Neal Shore
Details
Relugolix is the first oral GnRH receptor antagonist, which was previously shown to rapidly suppress testosterone levels. Neal Shore joins Alicia Morgans to discuss the results of the HERO phase 3 trial comparing the safety and efficacy of relugolix with leuprolide acetate in advanced prostate cancer patients. Relugolix is an oral, once a day medication, and the trial had a primary endpoint of non...
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free